307
Participants
Start Date
January 22, 2021
Primary Completion Date
September 6, 2023
Study Completion Date
September 6, 2023
DUR-928 30 mg
IV infusion
DUR-928 90 mg
IV infusion
Placebo+ Standard of Care (SOC)
IV infusion
Université libre de Bruxelles (ULB) - Hôpital Erasme, Brussels
Royal Prince Alfred Hospital, Camperdown
Nepean Hospital, Kingswood
Universitair Ziekenhuis Antwerpen (UZA), Edegem
Eastern Health - Box Hill Hospital, Box Hill
Mater Health - Mater Hospital Brisbane, South Brisbane
Royal Adelaide Hospital, Adelaide
Flinders Medical Centre, Bedford Park
Royal Perth Hospital, Perth
Sir Charles Gairdner Hospital, Nedlands
Landeskrankenhaus (LKH) - Universitätsklinikum Graz, Graz
Mount Sinai Hospital, New York
New York-Presbyterian - Weill Cornell Medical Center, New York
Northwell Health - North Shore University Hospital, Manhasset
Hôpital St Joseph, Marseille
MedStar Health - MedStar Georgetown University Hospital, Washington D.C.
University of Maryland Medical Center, Baltimore
Johns Hopkins Hospital, Baltimore
University of Virginia (UVA) Health - University Hospital, Charlottesville
Bon Secours Liver Institute of Richmond, Richmond
Virginia Commonwealth University Medical Center, Richmond
Centre Hospitalier Régional Universitaire (CHRU) Besançon - Hôpital Jean Minjoz, Besançon
Atrium Health, Charlotte
Medical University of South Carolina (MUSC) Health - University Medical Center, Charleston
Piedmont Atlanta Hospital, Atlanta
University of Alabama at Birmingham (UAB) Hospital, Birmingham
University of Louisville, Louisville
Cleveland Clinic, Cleveland
Richard Roudebush VA Hospital, Indianapolis
Henry Ford Hospital, Detroit
University of Minnesota Medical School, Minneapolis
Centre Hospitalier Universitaire (CHU) de Lille - Hôpital Jeanne de Flandre, Lille
Loyola University Medical Center, Maywood
Northwestern Memorial Hospital, Chicago
Rush University Medical Center, Chicago
University of Chicago Medical Center, Chicago
Washington University School of Medicine, St Louis
Saint Luke's Health System - Saint Luke's Hospital of Kansas City, Kansas City
University of Nebraska Medical Center (UNMC), Omaha
Hospices Civils de Lyon - Hôpital de la Croix-Rousse, Lyon
Tulane Medical Center, New Orleans
Methodist Dallas Medical Center, Dallas
Parkland Memorial Hospital, Dallas
Baylor Scott and White Health, Dallas
University of Texas Southwestern (Clements University Hospital), Dallas
University of Texas Southwestern Medical Center, Dallas
Baylor College of Medicine Medical Center, Houston
Houston Methodist Hospital, Houston
Doctors Hospital at Renaissance (DHR), Edinburg
Utah Health - The University of Utah Hospital, Salt Lake City
Mayo Clinic Hospital, Phoenix
University of New Mexico (UNM) Hospital, Albuquerque
Keck Hospital of University of Southern California (USC), Los Angeles
Cedars-Sinai Medical Center, Los Angeles
Southern California Research Center, Coronado
University of California San Francisco (UCSF) Medical Center, San Francisco
Stanford University Medical Center, Stanford
University of California Davis (UC Davis) Medical Center, Sacramento
Harborview Medical Center - University of Washington, Seattle
Yale University School of Medicine, New Haven
Tufts Medical Center, Boston
Massachusetts General Hospital, Boston
Rutgers-New Jersey Medical School, Newark
Barts Health NHS Trust - The Royal London Hospital, London
King's College Hospital NHS Foundation Trust, London
Imperial College Healthcare NHS Trust - St. Mary's Hospital, London
University Hospitals Plymouth NHS Trust - Derriford Hospital, Plymouth
Royal Free London NHS Foundation Trust Hospital, London
Lead Sponsor
Collaborators (1)
CTI Clinical Trial and Consulting Services
OTHER
Durect
INDUSTRY